PENICILLIN G BENZATHINE (pen-i-sill'in)
Bicillin, Bicillin L-A, Permapen Classifications: beta-lactam antibiotic; natural penicillin; Therapeutic: antibiotic; beta-lactam Prototype: Penicillin G potassium Pregnancy Category: B
|
Availability
300,000 units/mL, 600,000 units/mL, 1,200,000 units/2 mL, 2,400,000 units/4 mL injection
Action
Acid-stable, penicillinase-sensitive, long-acting form of penicillin G. Absorbed slowly in body because of extremely low
water solubility. Produces lower blood concentrations than other penicillin G compounds but has the longest duration of antimicrobial
activity of all other available parenteral or repository penicillins.
Therapeutic Effect
Effective against many strains of Staphylococcus aureus, gram-positive cocci, gram-negative cocci. Also effective against gram-positive bacilli and gram-negative bacilli.
Uses
Infections highly susceptible to penicillin G, such as streptococcal, pneumococcal, and staphylococcal infections, venereal
disease such as syphilis (including early, late, and congenital forms), and nonvenereal diseases (e.g., yaws, bejel, and
pinta). Also used in prophylaxis of rheumatic fever.
Contraindications
Hypersensitivity to penicillins or cephalosporins; lactation.
Cautious Use
History of or suspected allergy (eczema, hives, hay fever, asthma); renal disease, renal impairment; GI disease; pregnancy
(category B); infants, neonates.
Route & Dosage
Mild to Moderate Infections Adult: IM 1,200,000 U once/d Child: IM >27 kg, 900,000 U once/d; <27 kg, 300,000600,000 U once/d
Syphilis Adult: IM <1 y duration: 2,400,000 U as single dose; >1 y duration: 2,400,000 U/wk for 3 wk Child: IM Congenital: 50,000 U/kg as single dose
Prophylaxis for Rheumatic Fever Adult: IM 1,200,000 U q4wk Child: IM 1,200,000 U q34wk
|
Administration
Intramuscular
- Do not confuse penicillin G benzathine with preparations containing procaine penicillin G (e.g., Bicillin C-R).
- Make IM injection deep into upper outer quadrant of buttock. In infants and small children, the preferred site is the midlateral
aspect of the thigh.
- Shake multiple-dose vial vigorously before withdrawing desired IM dose. Shake prepared cartridge unit vigorously before
injecting drug.
- Select IM site with care. Injection into or near a major peripheral nerve can result in nerve damage.
- Inadvertent IV administration has resulted in arterial occlusion and cardiac arrest.
- Make injections at a slow steady rate to prevent needle blockage.
- Store at 15°30° C (59°86° F).
Adverse Effects (≥1%)
Body as a Whole: Local pain, tenderness, and fever associated with IM injection, chills, fever, wheezing,
anaphylaxis, neuropathy,
nephrotoxicity; superinfections, Jarisch-Herxheimer reaction in patients with syphilis.
Skin: Pruritus, urticaria, and other skin eruptions.
Hematologic: Eosinophilia, hemolytic anemia, and other blood abnormalities. Also see
PENICILLIN G POTASSIUM.
Interactions
Drug: Probenecid decreases
renal elimination; may decrease efficacy of
oral contraceptives.
Pharmacokinetics
Absorption: Slowly absorbed from IM site.
Peak: 1224 h.
Duration: 26 d.
Distribution: Crosses placenta; distributed into breast milk.
Metabolism: Hydrolyzed to penicillin in body.
Elimination: Excreted slowly by kidneys.
Nursing Implications
Note: See penicillin G potassium for numerous additional clinical implications.
Assessment & Drug Effects
- Determine history of hypersensitivity reactions to penicillins, cephalosporins, or other allergens prior to initiation of
drug therapy.
- Lab tests: Perform C&S tests prior to initiation of therapy and periodically thereafter. Perform periodic renal function
tests.
Patient & Family Education
- Report immediately to physician the onset of an allergic reaction. There is great risk of severe and prolonged reactions
because drug is absorbed so slowly.